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Abstract
The primary and secondary objectives of the Early Developmental Stages of
Substance Abuse Study (EDSP) are described along with a detailed description
of the overall design, special design features and instruments used. The EDSP is
a 5-year prospective study with three waves of assessments. Special design fea-
tures are the linkages with family genetic investigations as well as neuroendocri-
nological stress tests in high-risk subjects. Overall, 3,021 adolescents and young
adults aged 14–24 years are included. The response rate for the baseline investi-
gation was 71%. Diagnostic assessments were made by using a modified life-
time (baseline) and 12-month change version of the WHO-CIDI, adjusted for
DSM-IV. Modifications refer to a more detailed quantitative assessment of
symptoms and substance use variables as well as the inclusion of questions to
assess course of disorders and subthreshold diagnostic conditions.
OOOOOOOOOOOOOOOOOOOOOO
Background of the EDSP
The considerable overall deficit in knowledge about
substance use disorders motivated the federal German
government in 1994 to launch the ‘Biological and Psycho-
social Factors of Drug Abuse’ program coordinated by the
Ministry of Research and Technology. A major compo-
nent of this fairly comprehensive long-term research pro-
gram was the constitution of a working group in epidemi-
ology to study a wide variety of issues related to preva-
lence, risk factors as well as the natural course of sub-
stance abuse in various sites and regions. This collabora-
tive effort was labeled ANEPSA (Analytical Epidemiolo-
gy of Psychoactive Substance Abuse), bringing together
three major work groups: the Institute für Therapiefor-
schung (IFT, München) with the focus on the long-term
course and outcome of drug use as well as preventive
trials, the Psychiatric Hospital of the University of Lü-
beck, with the focus on the prevalence of substance use
disorders among 18- to 65-year-olds as well as the study of
remission from substance use disorders without formal
treatment, and the Max Planck Institute of Psychiatry
Unit for Clinical Psychology and Epidemiology for a lon-
gitudinal study on the early stages of substance abuse
(EDSP) in a representative sample of adolescents and
young adults aged 14–24 years. The ANEPSA group
meets regularly and coordinates both the use of identical
assessment instruments as well as comparable analytic
strategies to allow systematic comparisons and joint anal-
yses in the future. Two of the work groups also investigate
the same respondents in different research projects. This
paper describes the goals and methods used in the EDSP,
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Table 1. Diagnostic criteria for substance use disorders in
DSM-IV
Criteria for substance dependence
A A maladaptive pattern of substance use, leading to clinically sig-
nificant impairment or distress, as manifested by three (or more)
of the following, occurring at any time in the same 12-month peri-
od:
1 tolerance, as defined by either of the following:
(a) a need for markedly increased amounts of the substance to
achieve intoxication or desired effect
(b) markedly diminished effect with continued use of the
same amount of the substance
2 withdrawal, as manifested by either of the following:
(a) the characteristic withdrawal syndrome for the substance
(refer to criteria A and B of the criteria sets for withdrawal
from the specific substances)
(b) the same (or a closely related) substance is taken to relieve
or avoid withdrawal symptoms
3 the substance is often taken in larger amounts or over a longer
period than was intended
4 there is a persistent desire or unsuccessful efforts to cut down
or control substance use
5 a great deal of time is spent in activities necessary to obtain
the substance (e.g. visiting multiple doctors or driving long
distances), use the substance (e.g. chain-smoking), or recover
from its effects
6 important social, occupational, or recreational activities are
given up or reduced because of substance use
7 the substance use is continued despite knowledge of having a
persistent or recurrent physical or psychological problem that
is likely to have been caused or exacerbated by the substance
(e.g. current cocaine use despite recognition of cocaine-
induced depression, or continued drinking despite recogni-
tion that an ulcer was made worse by alcohol consumption)
Criteria for substance abuse
A A maladaptive pattern of substance use leading to clinically sig-
nificant impairment or distress, as manifested by one (or more) of
the following, occurring within a 12-month period:
1 recurrent substance use resulting in a failure to fulfill major
role obligations at work, school, or home (e.g. repeated
absences or poor work performance related to substance use;
substance-related absences, suspensions, or expulsions from
school; neglect of children or household)
2 recurrent substance use in situations in which it is physically
hazardous (e.g. driving an automobile or operating a machine
when impaired by substance use)
3 recurrent substance-related legal problems (e.g. arrests for
substance-related disorderly conduct)
4 continued substance use despite having persistent or recur-
rent social or interpersonal problems caused or exacerbated
by the effects of the substance (e.g. arguments with spouse
about consequences of intoxication, physical fights)
B The symptoms have never met the criteria for substance depen-
dence for this class of substance
focusing on the design and instruments chosen for the
baseline investigation and the subsequent follow-up.
The basic prerequisite for addressing the main objec-
tives of the EDSP, outlined below, is the use of substance-
specific diagnostic criteria allowing the determination of
the lifetime and current prevalence of symptoms of abuse
and dependence according to the explicit diagnostic crite-
ria of the Diagnostic and Statistical Manual of Mental Dis-
orders, 4th revision (DSM-IV) [1] with an appropriate reli-
able and valid casefinding instrument. These criteria are
comparable to the research criteria of the tenth version
of the International Classification of Diseases (ICD-10)
[2]. These new criteria enable researchers and clini-
cians to classify dependence and abuse for each specific
group of the following classes of substances: alcohol, am-
phetamines, cannabinoids, cocaine, hallucinogens, inhal-
ants, opioids, phencyclidine, sedatives/hypnotics/anxio-
lytics and others. Additionally, dependence may also be
diagnosed for nicotine and polysubstance use (table 1).
Objectives of the EDSP
With its focus on the early stages of substance abuse
the EDSP has three primary objectives:
(1) Determination of lifetime and cross-sectional prev-
alence and 1- to 4-year incidence of substance use, abuse
and dependence of various substances (nicotine, alcohol,
all types of illegal as well as prescription drugs) along with
information about mode and time of onset as well as asso-
ciated sociodemographic risk factors in a representative
population sample.
(2) Description of the natural course of substance use
patterns over a period of several years with emphasis on
the identification of developmental stages of substance
disorders and their relationship to various risk and pro-
tective factors, associated with changes from one stage to
another.
(3) Examination of the association of substance use dis-
orders with other psychopathological variables, including
temporary and secondary mental disorders as well as disor-
ders in the respondents’ family (family genetic factors).
Secondary objectives – along with supplementary pro-
jects – are:
(4) Identification of family genetic factors through sep-
arate interviews with the respondents’ parents to assess
the parents’ psychopathology, illness histories as well as
the respondents’ childhood history and early behavioral
problems as potentially important vulnerability and risk
factors for later substance abuse patterns. In addition, the
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Fig. 1. Design of the EDSP.
family atmosphere as well as child-rearing styles are eval-
uated.
(5) Supplementary experimental investigations (popu-
lation lab) in high-risk respondents to assess the critical
role of neurobiological and cognitive dysfunctions in
stress and anxiety regulation as predictors for later sub-
stance abuse.
Design and Methods
Overall Design Issues
The overall design chosen to investigate these issues is
a prospective longitudinal design based on a random pop-
ulation sample of residents in the Munich area, aged 14–
24 years. The lower age limit of 14 years was chosen,
because first substance use exposure (nicotine, alcohol)
has been reported to occur at a fairly young age (13–15
years), with other substances usually being reported later
in adolescence. This lower age limit is also reasonable in
terms of the instruments used, because the age of 14 is the
youngest age for which some psychometric investigations
are available for the EDSP core instruments (see below).
As an upper limit for inclusion, the age of 24 years was
chosen. The regional restriction to Munich residents al-
lowed and facilitated the conduct of above-mentioned
family genetic, as well as supplementary in-depth analysis
of high-risk respondents at reasonable costs.
For practical and theoretical reasons we also limited
the number of follow-up investigations over the 5-year
funding period to three waves. As emphasis was laid on
early stages of substance abuse patterns, subjects aged 14–
17 years old at baseline were examined three times (base-
line, T1 and T2) with approximately 18-month time inter-
vals, whereas subjects aged 18–24 years were assessed
only twice (baseline and 36 months later). Thus, overall, a
period of almost 4 years will be covered.
The family assessments as well as the laboratory stud-
ies were conducted almost exclusively in the time between
the baseline (T0) and T1 follow-up interview, in order to
use the data as predictors for outcome at the final assess-
ment. Separate face-to-face interviews with the respon-
dents’ parents were carried out to evaluate childhood
development and childhood disorders together with fami-
ly genetic variables. Figure 1 gives a graphical representa-
tion of the overall design.
Sampling and Response Rates
The sample was drawn in November 1994 from the
respective population registry offices (Einwohnermel-
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Table 2. Demographic distribution of the sampled population, the respondents unweighted and weighted, and the
population in metropolitan Munich
Sample
n %
Respondents unweighted
n % of
sample
% of
respondents
Respondents
weighted
n %
Metropolitan
Munich, in 1990
n %
Total 4,263 100.0 3,021 70.9 100.0 3,021 100.0 110,363 100.0
Men, total 2,129 49.9 1,533 72.0 50.7 1,493 49.4 54,458 49.3
14–15 632 14.8 470 74.3 15.6 241 8.0 8,034 7.3
16–17 331 7.8 244 73.6 8.1 223 7.4 8,128 7.4
18–19 320 7.5 241 75.4 8.0 221 7.3 7,946 7.2
20–21 355 8.3 243 68.5 8.0 253 8.4 9,760 8.8
22–24 497 11.6 335 67.5 11.1 554 18.3 20,590 18.7
Women, total 2,134 50.1 1,488 69.7 49.3 1,528 50.6 55,905 50.7
14–15 588 13.8 433 73.6 14.3 234 7.7 7,922 7.2
16–17 326 7.7 248 76.0 8.2 222 7.3 7,913 7.2
18–19 314 7.4 219 69.6 7.2 224 7.4 8,568 7.8
20–21 393 9.2 255 64.8 8.4 295 9.8 10,638 9.6
22–24 520 12.2 333 64.1 11.0 553 18.3 20,864 18.9
deämter, see below) of the city and each of the 29 counties
of Munich. The base population were all those born
between June 1st 1970 and May 31st 1981, registered as
living in these localities as their primary place of resi-
dence and having German citizenship. These registers can
be regarded as highly accurate because of regular updates
as well as strict enforcement by law and the police.
Munich (population 2.6 million) is the capital of Ba-
varia with a high proportion of the population being
employed in education and service settings (32%) fol-
lowed by manufacturing industries (22%) and trade
(18%). As in other German metropolitan areas, there is a
considerable proportion of foreign guest workers and mi-
grants (21%). Compared with other cities in Germany,
only a relatively small proportion of Munich’s residents
are unemployed (6%) at the time of the baseline assess-
ment.
The random sample was proportionally drawn to mir-
ror the distribution of 14- to 24-year-olds in Munich.
Based on our power calculation for substance use we
determined that we needed at least 3,000 respondents for
the descriptive epidemiological part of the study. Because
the study is designed as a longitudinal panel with special
interest in the development of substance disorders, we
had to make sure that we attained a sufficiently high num-
ber of subjects without any substance use at baseline.
Therefore, we sampled a disproportionately high number
of 14- and 15-year-old subjects. This was necessary as
these age groups are those with the least number of mem-
bers in the population. Fourteen- to 15-year-olds were
sampled at twice the probability of persons 16–21 years of
age, and 22- to 24-year-olds were sampled at half this
probability.
From the total of 4,809 sampled individuals, 4,263 were
located and determined to be eligible for the study. Sam-
pled individuals who were not located were disproportion-
ately older and uncontactable either because they had
moved outside the metropolitan Munich area in the time
interval between their registration and the beginning of the
study in 1995 (8.8%) or could not be associated with the
listed address during the field work period (2.4%).
From the 4,263 individuals a total of 3,021 interviews
were completed resulting in a response rate of 71%. In
addition, partial information was obtained on an addi-
tional 6.2% but these findings will not be reported here.
Refusal to participate (18.2%) was by far the most fre-
quent reason for nonresponse followed by a reported lack
of time (3.3%), failure to contact anyone in the identified
household (3.1%) and failure to contact the sampled indi-
vidual in an identified household (3.0%). Demographical-
ly, nonresponse increased with age, especially among
women whose nonresponse rates were slightly higher than
those of men among individuals of 18+ years of age (ta-
ble 2). The slightly higher proportion of refusals among
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Table 3. Distribution (%) of sociodemographic variables
Total Men Women
Type of education
Hauptschule 11.0 12.5 9.5
Realschule 18.4 15.4 21.2
Fachhochschule 4.9 5.4 4.3
Gymnasium 30.3 29.3 31.3
University 35.0 37.0 33.1
Drop out 0.5 0.4 0.6
Living arrangement
With parents 63.9 68.5 58.8
Alone 23.1 21.8 24.4
With partner 9.5 7.9 11.1
With spouse 3.7 1.8 5.7
Employment
Student 36.2 36.8 35.5
University 35.0 37.0 33.1
Unemployed 4.9 4.8 5.0
In home 1.4 0.1 2.5
Employed 22.6 21.3 23.9
Social class
I Lowest 1.0 1.4 0.6
II Lower middle 6.8 7.4 6.1
III Middle 60.2 58.5 61.8
IV Upper middle 28.8 29.3 28.4
V Upper 3.2 3.4 3.1
Financial situation
Bad, very bad 8.2 9.4 7.1
Not good or bad 28.0 27.9 28.2
Good 52.8 52.0 53.5
Very good 11.0 10.7 11.3
Urbanicity
Urban Munich 75.1 73.5 76.7
Suburbs 24.9 26.5 23.3
women was due to increased reports of lack of time, fail-
ure to contact anyone in the household and failure to con-
tact the sampled individual. Because previous studies
have found non-response and attrition to be significantly
higher among persons with psychiatric disorders [3–5],
future analyses will examine this area in more detail.
To account for the differential sampling probabilities
and nonresponse oversampling of persons expected to be
14–15 years of age at interview and undersampling of 21-
to 24-year-olds, individuals who were not located as well
as nonresponse, the data have been adjusted by age, sex
and geographic location to match the distribution of the
sampling frame. Table 2 presents the demographic distri-
bution of the sample and respondents and shows the
decreasing response rates with age, the adjusted distribu-
tion of respondents that results from using weighted data,
and a comparison of the weighted respondent distribution
to that of metropolitan Munich.
Table 3 shows the distribution of some sociodemo-
graphic variables in the sample. Approximately one-third
is currently attending or has attended gymnasium (sec-
ondary education between ages of 10 and 19 that prepares
students for entrance to university) and another third uni-
versity. Lower school educational status is reported by
11% (Grund- or Hauptschule = mandatory basic school)
and (Realschule = an intermediate type of advanced
school between Gymnasium and Hauptschule allowing
qualification for specific university curricula) by 18.4%.
Consistent with the mandatory schooling laws, there are
only 0.5% that have dropped out of any type of these
schools completely without any sort of qualification. Only
22.6% of all study participants are currently in the work
force and 4.9% are registered as being unemployed. The
majority of respondents are currently living with their
parents, only a few are currently married. The vast major-
ity of respondents were classified as middle class, with
only 7.8% belonging to the lower social classes.
Diagnostic Assessment
Psychopathological and diagnostic assessments were
based on the Computer-Assisted Personal Interview
(CAPI) version of the Munich-Composite International
Diagnostic Interview (M-CIDI) [6, 7].
The M-CIDI is a modified version of the World Health
Organization (WHO) CIDI, version 1.2 supplemented by
questions to cover DSM-IV and ICD-10 criteria [6, 7].
The M-CIDI (table 4) allows for the assessment of symp-
toms, syndromes and diagnoses of 48 mental disorders
(not counting various subtypes of main disorders) along
with information about onset, duration, clinical and psy-
chosocial severity (see table 4). Diagnostic analysis is
based on the M-CIDI diagnostic package DSM-IV diag-
nostic algorithms [8]. Diagnostic findings reported in this
paper are based on the M-CIDI/DSM-IV algorithms with-
out using the DSM-IV hierarchy rules, unless otherwise
stated in the text.
The M-CIDI inlcudes numerous features that have
been developed and tested in several methodological
studies with the CIDI or modifications thereof [9]. These
include: (a) the use of symptom lists and memory aids that
are assembled in a separate response booklet to improve
lifetime recall, ease memory search and shorten length of
the inverviews in the somatization and anxiety section;
(b) the addition of symptom and criteria lists to help the
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proband answer onset and recentness questions, for ex-
ample, in the alcohol section to assess onset and recent-
ness of reported dependence symptoms; (c) the imple-
mentation of dimensional ratings various sections for the
assessment of impairment associated with core syn-
dromes; (d) the rating of key syndromes specifically for
their first, worst and most recent occurrence, with addi-
tional questions to allow derivation of pure cross-section-
al measures; (e) the incorporation of dimensional symp-
tom scales such as the SCL-90-R [10], behavioral inhibi-
tion and premenstrual syndrome into the interview to
enable us to measure changes in key psychopathological
dimensions; (f) the implementation of separate current
and lifetime ratings for the degree of impairment in var-
Table 4. The M-CIDI DSM-IV diagnoses (with corresponding ICD-10 F code) and optional modules
F No. Diagnosis
A. M-CIDI standard diagnoses
1. Mental disorders due to general medical conditions
Various subtypes are available (F06.0, F06.2, F06.30, F06.32, F06.33, F06.4,
F06.41, F06.42) with precautionary notes
2. Substance-related disorders
F10.1 Alcohol Abuse
F10.2 Alcohol Dependence
F11.1 Opioid Abuse
F11.2 Opioid Dependence
F12.1 Cannabis Abuse
F12.2 Cannabis Dependence
F13.1 Sedative-, Hypnotic- or Anxiolytic Abuse
F13.2 Sedative-, Hypnotic- or Anxiolytic Dependence
F14.1 Cocaine Abuse
F14.2 Cocaine Dependence
F15.1 Amphetamine Abuse
F15.2 Amphetamine Dependence
F16.1 Hallucinogen Abuse
F16.2 Hallucinogen Dependence
F17.2 Nicotine Dependence
F18.1 Inhalant Abuse
F18.2 Inhalant Dependence
F19.10 Phencyclidine Abuse
F19.12 Other Substance Abuse
F19.20 Phencyclidine Dependence
F19.21 Polysubstance Dependence
F19.22 Other Substance Dependence
3. Schizophrenia and other psychotic disorders
F2X Unspecified screening
4. Mood disorders
For all disorders subtypes according to severity, specific features, such as
melancholic subtype, psychotic features, post partum etc. are available with
their F codes
F30.X Bipolar I Disorder, single manic episode
F31.0 Bipolar I Disorder, most recent episode, hypomanic
F31.X Bipolar I Disorder, most recent episode, manic
(or depressed)
F31.6 Bipolar I Disorder, most recent episode, mixed
F32.X Major Depressive Disorder, single episode
F33.X Major Depressive Disorder, recurrent
F34.1 Dysthymic Disorder
F No. Diagnosis
5. Anxiety disorders
F40.00 Agoraphobia without the history of panic disorder
F40.01 Panic Disorder with Agoraphobia
F40.1 Social Phobia
F40.21 Specific Phobia, Animal-Type
F40.22 Specific Phobia, Environmental-Type
F40.23 Specific Phobia, Blood/Injury-Type
F40.24 Specific Phobia, Situational Type
F40.25 Specific Phobia, other
F40.9 Anxiety Disorder NOS
F41.0 Panic Disorder without Agoraphobia
F41.1 Generalized Anxiety Disorder
F42.8 Obsessive-Compulsive Disorder
F43.1 Posttraumatic Stress Disorder
6. Somatoform and dissociative disorders
Various subtypes and options available
F44.X Conversion Disorders
F45.0 Somatization Disorder
F45.1 Undifferentiated Somatoform Disorder
F45.2 Hypochondriasis
F45.4 Pain Disorder
7. Eating disorders
F50.0 Anorexia Nervosa
F50.2 Bulimia Nervosa
F50.9 Eating Disorders NOS
8. Cognitive impairment
B. Other diagnostic and non-diagnostic modules and features
of M-CIDI
– Attention Deficit/Hyperactivity Disorder
– Oppositional Defiant Disorder
– Separation Anxiety Disorder
– Conduct and Antisocial Personality Disorder
– Premenstrual Syndrome
– Family Genetic Module
– Subthreshold Disorders for most above mentioned multi-
criteria diagnoses
– Health service utilization and treatment module
– Life events and life conditions module
– Dimensional rating scales for core syndromes
– Impairment and disability modules for each section
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Table 5. Constructs and instruments
Constructs Instruments Administration
time, min
T0 T1 T2
1 Mental disorders and substance use CIDI (and CIDI 12-month change version)
dimensional rating scales, parents’ ratings
35 X X X
2 Development and prior life course early developmental history, self-report and
parents’ report, including parents’ psycho-
pathology
10 X
3 Substance use situtation, attitudes and behavior substance use questionnaire, alcohol 15 X X X
4 Personality childhood inhibition and other questionnaires 10 X
5 Life events, daily hassles and coping life-events (MEL), daily hassles and coping 15 X X
6 Family and familial socialization family developmental history scale 10 X
7 Disorder-specific health beliefs HBS scales 12 X X
8 Impairments and disability M-CIDI module 8 X X X
9 Health service utilization M-CIDI module 8 X X X
10 Resilience factors questionnaire and rating 5 X X X
ious social roles (work, school, leisure time, partner, etc.)
for each diagnostic section; (g) the addition of more open-
ended questions describing the person’s problems, allow-
ing the clinical editor to judge the appropriateness of the
CIDI ratings; (h) the abandonment in some sections of the
symptom-specific probe questions of the original CIDI in
favor of syndrome-based coding, and (i) the deletion of
many of the CIDI’s skip rules in several diagnostic sec-
tions to allow for the study of subthreshold conditions (i.e.
mixed anxiety-depression disorders and brief recurrent
syndromes) and to improve the CIDI’s ability to measure
more subtle changes in diagnostic status because we
expect considerably less diagnostic stability in adolescents
than in adults.
The mean duration for completing the computerized
(CAPI) M-CIDI, including questionnaires, was two hours.
The decision to use the CAPI-CIDI was made after the
pilot test where CAPI interviews were shown to reduce
the length of interview administration and to help avoid
interviewer coding, skip rule and probe question errors.
The CAPI version of the M-CIDI was supplemented by a
separate respondents’ booklet that included several scales
and questionnaires that were of importance for the longi-
tudinal component of our study. In addition, there were
cognitive aids to help and assist the respondent in dating
symptom onset and recency and in answering compli-
cated symptom questions and identifying course patterns.
More detailed information on the substance section of the
M-CIDI along with data about its reliability are reported
elsewhere in this issue.
Other Instruments and Constructs
The study uses primarily standardized instruments
(questionnaires and interviews) with known psychomet-
ric properties to measure psychopathology as well as
explanatory constructs. The fairly high number of inter-
viewers with various theoretical backgrounds and experi-
ence as well as the stability with which these instruments
are applied over the study period made high reliability as
well as standardization a basic requirement in choosing
instruments.
Table 5 briefly describes the main instruments and
constructs with their average administration time.
Interviewers and Interviewer Training
The length of the study period made it unlikely to use
the same interviewers throughout the whole study. Inter-
viewers were carefully selected from two sources with
prior expertise in health or clinical interviewing as the
first and primary selection criterion. The first source was
clinical interviewers from other projects of our unit with
experience in conduction CIDI interviews. Most of these
staff members were psychologists in postgraduate training
for psychotherapy, most of whom were also involved over
a period of at least 6 months in the further development of
the M-CIDI as well as other study instruments (pilot stud-
ies). The second source were full-time professional health
research interviewers. The health research interviewers
were recruited from Infratest-Gesundheitsforschung, a
survey company specializing in health research, commis-
sioned to perform the sampling and field work coordina-
tion in the baseline phase of the EDSP. These survey
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interviewers from Infratest were however only used in the
baseline investigation because of the relatively high costs
involved. In addition, assessment in the subsequent fol-
low-ups T1 and T2 required some clinical ratings by the
interviewers to map the clinical course of disorders.
All interviewers underwent several screening stages
and were finally chosen from an initial group of 67 appli-
cants. Ten clinical interviewers and 25 health survey
interviewers with varying professional backgrounds did
all the assessments in the baseline interview. They had all
received 2 full weeks of training, which included the CIDI
standard training components. This training period was
followed by at least 10 practice interviews that were close-
ly monitored by our staff. Immediately prior to the begin-
ning of the study, 1 day of pre-field training was done to
stress the important points and techniques and increase
the motivation of the interviewers.
Field Work
To assist interviewers in establishing contacts or with
technical issues and to answer any questions from pro-
bands, a telephone hotline was installed. After contacting
the probands by letter and phone, a time and location for
the interview was added. Most interviews took place at
the time of first contact which was in the proband’s home.
At the beginning of the interview the written data protec-
tion explanation was given to the probands and a gift was
given as an incentive for participation. The standard gift
was two telephone cards each worth DM 12 (USD 8).
To enhance participation, several special efforts were
made during the study: (a) the addresses of at least 4 con-
tacts were given to another interviewer of the opposite sex
and, overall, at least 10 attempts at contact (maximum
15) were made at different times of the day and week
including weekends; (b) interviewers who were especially
successful at contacting were trained for recontacting dif-
ficult-to-contact probands; (c) motivation letters were
sent to 100 unreachable probands with a telephone card
enclosed and the request to call back, and (d) to motivate
the last indecisive probands, up to DM 60 (USD 40) was
offered. The 71% response rate with a total of n = 3,021
completed interviews was reached by the end of July
1995. In the beginning of the study the interviewers had to
contact the editors after having completed three to five
interviews and, throughout the field period, when hand-
ing over completed interviews. This gave interviewers the
opportunity to receive help regarding technical and con-
tent aspects of the interview.
Interviewers were closely monitored throughout the
field period by both the Infratest field staff as well as spe-
cially trained M-CIDI clinical editors. This procedure
ensured that within a week of submission to the clinical
editor interviews were checked according to a standard
procedure for both formal consistency as well as appro-
priate recording techniques. During these weekly editing
sessions, detailed feedback was given to every interviewer
to avoid erros in later interviews. The personal feedback
for interviewers was maintained throughout the study to
assure a high quality of administration and to motivate
the interviewers. The editors also gave instructions for
reassessments of missing values or questionnaires. The
correct administration of interviews was checked by ran-
dom follow-up phone calls to probands.
Statistical Analyses
As described above (fig. 1), the EDSP study design
calls for a baseline assessment (T0) and two follow-up
interviews (T1, T2) at approximately 18-month intervals,
thereafter the first of which (T1) is administered only to
the subpopulation of respondents initially 14–17 years of
age. Following this longitudinal panel design, lifetime
symptomatology is assessed at baseline with the lifetime
version of the M-CIDI allowing for cross-sectional 12-
month diagnoses as well as the retrospective assessment of
prior syndromes prior to the 12 months. Thus, these base-
line data also allow for evaluating onset, course and remis-
sion characteristics with the important caveat that these
data are retrospective. Nevertheless, in this issue we
report such retrospective data about prior lifetime course
of disorders in order to develop and tentatively test
hypotheses that will be subject to a more rigorous test on
the basis of the forthcoming prospective data. Interim
symptomatology between the baseline and the two subse-
quent follow-up investigations is assessed at each follow-
up by using the M-CIDI 12-months version. Because it is
technically not feasible to keep a constant time interval
between follow-up investigations, because of the consider-
able number of cases as well as the variations in which
they are willing to participate, we assess both 12-month as
well as interim symptomatology.
Sample and Weighting
Because the data collected as part of the EDSP study is
meant for use in descriptive as well as analytical research,
stratified sampling was incorporated into the panel design
with 14- to 15-year-olds being sampled at twice the proba-
bility of 16- to 21-year-olds and 22- to 24-year-olds being
sampled at half this probability. This sampling strategy
allows for sufficient precision in not only the estimation
of measures for the entire population, i.e. 14- to 24-year-
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Table 6. Definitions
Measures Explanations
Incidence incidence refers to new outcomes among mem-
bers of the population at risk; two measures of
incidence are the incidence density, a rate, and
cumulative incidence: a proportion; other mea-
sures of incidence which are often presented as
proportions include; first incidence, recurrence,
and total incidence
Prevalence prevalence refers to all outcomes which exist
within a specified time frame; prevalence in-
cludes not only incident outcomes such as first
incidence and recurrence but also persistent out-
comes
First
incidence, %
incident episode in the T0 population without a
previous episode
Recurrence, % incident episode in the T0 population with a pre-
vious episode but not in an episode at baseline
Total
incidence, %
incident episode in the T0 population with no
episode at baseline, regardless of past episode
experience; the total of first incident and recur-
rent outcomes
Persistence or
chronicity, %
the continuation of a diagnosis episode from one
time frame to a subsequent time frame in the
absence of interim remission
Remission, % a state of subthreshold diagnosis having been pre-
ceded by a threshold diagnostic state; the sub-
threshold state can be described as partially or
fully remitted
Odds ratio a single summary measure which estimates the
strength and nature of association between an
exposure and an outcome is the odds ratio (OR);
in the odds ratio, the numerator is the odds of an
outcome among those with an exposure (a/c) and
the denominator is the odds of an outcome
among those without an exposure (b/d); an OR
equal to 1.0 indicates no relationship between the
exposure and outcome, an OR greater than 1.0
represents a positive relationship, and an OR less
than 1.0 represents a negative relationship be-
tween the exposure and outcome
Hazard rate the hazard rate is interpreted as the instantaneous
potential for the outcome of interest to occur, giv-
en it has not occurred at an earlier time point
Cumulative
incidence
cumulative incidence is analogous to the failure
function, the complement of the survival func-
tion, and describes the probability of outcome
occurrence before time t
olds, but also in the estimation of measures used for com-
parative analyses within the age group of primary interest,
i.e. 14- to 15-year-olds.
As a result of the stratified sampling design, relative
weights inversely proportional to the sampling fraction
are used in the estimation of measures which are general-
ized to the sampling frame. This means that 14- to 15-
year-olds receive a weight of ½, reflecting their probability
of selection which is twice that of 16- to 21-year-olds, and
22- to 24-year-olds receive a weight of 2, reflecting their
probability of selection which is one-half that of 16- to
21-year-olds. In addition, a nonresponse weight is used
which adjusts the age, gender and geographic distribution
of the respondents to that of the registered sampling frame
(see Lee et al. [11] for further explanation).
Measures
The two most common measures used throughout the
following papers will be lifetime and 12-month preva-
lence. Because lifetime prevalence is defined as the cumu-
lative incidence [12, 13] only the incident episode of the
diagnosis is counted and by definition the incident epi-
sode has met full criteria for dependence. However, in the
estimation of 12-month prevalence, respondents exper-
iencing incident episodes in the past 12 months are
counted together with respondents experiencing a recur-
rent episode or a persistent episode in the past 12 months,
which need only express one of the dependence symp-
toms. To clarify this distinction, what has historically
been referred to as lifetime prevalence is sometimes
referred to in the following papers as lifetime cumulative
incidence (table 6).
To account for the bias introduced by the differing
lenghts of follow-up time for each respondent, i.e. they
have different ages, survival analysis was used in analyzing
the data where appropriate [12, 14–15]. Hazard and cumu-
lative incidence curves for age at first drink and alcohol
diagnoses were calculated using life table methods and the
comparison of curves was done using the log-rank test. In
the figures which are presented for the alcohol diagnoses,
the hazard can be interpreted as the age-specific risk for the
outcome and the failure function, the complement of the
survival function, as the cumulative incidence, a propor-
tion whose numerator consists of a count of incident out-
comes and denominator of a count of the population at
risk. These interpretations of the hazard and failure func-
tions are based on the assumptions that the hazard is con-
stant across a given age interval allowing it to be inter-
preted as a uniform rate within the interval and that low
rates are an accurate approximation of the risk.
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Conclusion
To conclude, the EDSP can be regarded as both a more
descriptive prevalence and incidence study of mental dis-
orders, with emphasis on various substance use syn-
dromes and disorders as well as a causal epidemiological
investigation of vulnerabilities, risk and resilience factors.
These two objectives require a complex design and a com-
prehensive assessment of various domains that can best
be described as a population laboratory. This means, by
selecting subgroups from the representative sample of
interest for more in-depth studies, such as case-control or
experimental studies in high-risk subjects, we use our
sample of 3.021 as a laboratory from which subjects can
be selected. This offers the possibility – unlike to studies
in patient and convenience samples – to study key hy-
potheses in the area of substance abuse, such as about the
influence of family genetic variables or on the critical role
of stress-dysregulation patterns [16] in groups of cases
that could be still representative for the respective target
population.
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